Pure Financial Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-20,000
Closed -$92K 100
2016
Q1
$92K Buy
+20,000
New +$92K 0.03% 96